Shares of Vitalhub Corp. (TSE:VHI – Get Free Report) have earned a consensus recommendation of “Buy” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is C$13.25.
A number of equities research analysts have issued reports on the company. TD Securities increased their price target on Vitalhub from C$13.00 to C$14.00 and gave the company a “buy” rating in a research report on Monday, March 31st. National Bankshares set a C$14.00 price target on Vitalhub and gave the company an “outperform” rating in a research report on Tuesday, June 10th. National Bank Financial raised Vitalhub to a “strong-buy” rating in a research report on Monday, June 9th. Scotiabank increased their price target on Vitalhub from C$14.00 to C$14.50 and gave the company an “outperform” rating in a research report on Friday, June 20th. Finally, Raymond James Financial increased their price target on Vitalhub from C$13.50 to C$14.00 and gave the company an “outperform” rating in a research report on Friday, June 20th.
View Our Latest Research Report on VHI
Vitalhub Price Performance
Insider Buying and Selling at Vitalhub
In other Vitalhub news, Director Francis Nelson Shen bought 25,000 shares of the business’s stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of C$10.23 per share, with a total value of C$255,750.00. Company insiders own 18.57% of the company’s stock.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Stories
- Five stocks we like better than Vitalhub
- Dividend Payout Ratio Calculator
- Tesla Stock Could Accelerate on New EV Tax Legislation
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why Marvell Could Be the Smartest AI Bet Under $80
- What Do S&P 500 Stocks Tell Investors About the Market?
- Navigating Solar Headwinds: 3 Stocks Built to Last
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.